Announcement

Uganda declares Ebola outbreak

The health authorities in Uganda today declared an outbreak of Ebola after a case of the Sudan ebolavirus was confirmed in Mubende district in the central part of the country.  The Uganda Virus Research Institute confirmed the case after testing a sample taken from a 24-year-old male. This follows an investigation by the National Rapid Response team of six suspicious deaths that have occurred in the district this month. There are currently eight suspected cases who are receiving care in a

Ghana prepares for Marburg disease outbreak

The government of West African state of Ghana has announced it is swiftly setting up preparations for a possible outbreak response for Marburg virus disease following the announcement of the country’s first-ever reported suspected cases. Ghana has announced the preliminary finding of two cases of Marburg virus disease and if confirmed these would the first such infections recorded in the country. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease.  Preliminary analysis of

DR Congo’s 14th Ebola outbreak is over

The Democratic Republic of the Congo today declared the end of the Ebola outbreak that erupted less than three months ago in Mbandaka, the capital of Equateur Province in the northwest. It was the third outbreak in the province since 2018 and the country’s 14th overall. With greater experience in Ebola control, national emergency teams, with the support from World Health Organization (WHO) and partners, mounted a swift response soon after the outbreak was declared on 23 April, rolling out key

The world’s first pill to treat COVID-19 set for approval

Merck and Merck and Ridgeback Biotherapeutics today announced that the submission of an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. The companies are actively working with regulatory agencies worldwide to submit applications for emergency use or marketing authorization in the coming months. The submission is based on positive results

White House confirms plans to nominate Africa CDC head to lead PEPFAR

The White House has confirmed that President Joe Biden will nominate Dr. John N. Nkengasong as Ambassador-at-Large and Coordinator of United States Government Activities to Combat HIV/AIDS Globally at the Department of State. The Ambassador-at-Large leads, manages, and oversees the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) – the largest commitment by any nation to address a single disease in history, prevent millions of HIV infections, save lives, and make progress towards ending the HIV/AIDS epidemic. If confirmed,

NAFDAC raises alarm on the use of anti-inflammatory drugs

Late October 2020, Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) said it received a report about the US FDA’s warning on the use of nonsteroidal anti-inflammatory drugs (NSAIDs) around 20 weeks or later in pregnancy which may cause rare but serious kidney problems in an unborn baby. This can result in low amniotic fluid. “After about 20 weeks of pregnancy, the unborn babies’ kidneys produce most of the amniotic fluid, so kidney problems can lead to low